A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The MIRTOS Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 336 participants.
Also called NCT02429271
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 336 participants
- Sponsor
- Hellenic Cardiovascular Research Society
- Registry
-
NCT02429271
-
- Other papers using this trial's data
- Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Greece
- Registry status
- Completed
Technical summary
Registry record NCT02429271. Randomized; single masking; primary purpose treatment. Start 2015-08 (registry gives no type); primary completion 2019-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study
- Acronym
- MIRTOS
- Condition
- Myocardial Infarction
- Condition
- ST Segment Elevation Myocardial Infarction (STEMI)
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Clopidogrel
- Intervention (Procedure)
- Percutaneous Coronary Intervention (PCI (percutaneous coronary intervention))
- Intervention (Procedure)
- Coronary Angiography
- Lead sponsor
- Hellenic Cardiovascular Research Society
Record details
- Record id
cardio:ct-nct02429271- Content hash
2610db6c34c3729dcaa399f37ca8a51ca813d47c00db8e19b8c97860d3756cd3